Mar 3, 2026 04:05PM
Feb 2, 2026 06:21AM
Jan 13, 2026 07:32AM
Jan 13, 2026 07:30AM
Dec 17, 2025 08:00AM
Dec 17, 2025 08:00AM
Dec 9, 2025 07:58AM UBS Reiterates Buy Rating on NeuroPace Inc (NPCE) Post NAUTILUS Trial Results
Dec 8, 2025 08:01AM
Dec 8, 2025 08:00AM
Dec 2, 2025 08:01AM
Nov 10, 2025 09:21AM
Nov 5, 2025 06:20AM
Nov 5, 2025 06:04AM
Nov 4, 2025 04:05PM NeuroPace Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
Aug 14, 2025 06:04AM
Aug 13, 2025 05:22AM
Aug 12, 2025 04:05PM
Jun 26, 2025 08:01AM
Jun 16, 2025 07:00AM
Jun 12, 2025 07:20AM
May 27, 2025 08:03AM NeuroPace (NPCE) Announces Preliminary Results from One-Year Data in NAUTILUS Study
May 27, 2025 08:00AM
Apr 8, 2025 08:02AM
Apr 8, 2025 08:00AM
Mar 4, 2025 04:05PM
Dec 3, 2024 04:05PM
Nov 4, 2024 04:06PM
Nov 4, 2024 04:05PM NeuroPace Announces FDA Submission of Three-Year Data from Post-Approval Study of the RNS System in Focal Epilepsy
Sep 4, 2024 04:06PM
Sep 4, 2024 04:05PM
Mar 5, 2024 04:05PM
Jan 8, 2024 07:20AM
Jan 8, 2024 07:03AM
Dec 21, 2023 07:07AM
Nov 6, 2023 04:03PM NeuroPace Reports Third Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance
Oct 17, 2023 04:06PM
Oct 17, 2023 04:05PM
Aug 8, 2023 04:03PM
Nov 30, 2022 08:00AM
Oct 11, 2022 08:00AM
Aug 11, 2022 04:02PM
Aug 11, 2022 04:02PM NeuroPace Announces Distribution Agreement with DIXI Medical USA, Provider of Intracranial Electrodes and Instruments for Neurosurgery
Aug 11, 2022 04:02PM
May 4, 2022 08:00AM
Mar 10, 2022 04:02PM
Mar 10, 2022 04:02PM
Nov 10, 2021 04:03PM
Nov 10, 2021 04:03PM
Nov 10, 2021 04:02PM NeuroPace Receives IDE Approval to Initiate NAUTILUS Pivotal Study of its RNS System for Idiopathic Generalized Epilepsy
Oct 19, 2021 04:03PM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All